A
Allison Citro
Researcher at Boston University
Publications - 5
Citations - 1144
Allison Citro is an academic researcher from Boston University. The author has contributed to research in topics: Stress granule & Neurodegeneration. The author has an hindex of 5, co-authored 5 publications receiving 994 citations.
Papers
More filters
Journal ArticleDOI
Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue
Liqun Liu-Yesucevitz,Aylin Bilgutay,Yong Jie Zhang,Tara Vanderwyde,Allison Citro,Tapan Mehta,Nava Zaarur,Ann C. McKee,Robert Bowser,Michael Y. Sherman,Leonard Petrucelli,Benjamin Wolozin +11 more
TL;DR: It is shown that TDP-43 can be induced to form inclusions in cell culture and that most T DP-43 inclusions co-localize with SGs, which are cytoplasmic RNA granules that consist of mixed protein - RNA complexes.
Journal ArticleDOI
Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity.
Tara Vanderweyde,Daniel J. Apicco,Katherine Youmans-Kidder,Peter E.A. Ash,Casey Cook,Edroaldo Lummertz da Rocha,Karen Jansen-West,Alissa A. Frame,Allison Citro,John D. Leszyk,Pavel Ivanov,Jose F. Abisambra,Martin Steffen,Hu Li,Leonard Petrucelli,Benjamin Wolozin +15 more
TL;DR: expression studies show that tau regulates the distribution of TIA1, and tau accelerates stress granule (SG) formation, and these studies suggest that the pathophysiology of tauopathy requires an intimate interaction with RNA-binding proteins.
Journal ArticleDOI
Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies.
Tara Vanderweyde,W. Haung Yu,Megan M. Varnum,Liqun Liu-Yesucevitz,Allison Citro,Tsuneya Ikezu,Karen Duff,Benjamin Wolozin +7 more
TL;DR: Study of RNA-binding proteins and SG biology highlights novel pathways interacting with the pathophysiology of AD, providing potentially new avenues for identifying diseased neurons and potentially novel mechanisms regulating tau biology.
Journal ArticleDOI
Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2).
TL;DR: A novel interaction between LRRK2 and the Rho GTPase, Rac1, is demonstrated, which plays a critical role in actin cytoskeleton remodeling necessary for the maintenance of neurite morphology and provides a novel pathway through which L RRK2 might modulate cellular dynamics and contribute to the pathophysiology of Parkinson disease.
Journal ArticleDOI
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity
Julien Dusonchet,Julien Dusonchet,Hu Li,Maria Guillily,Min Liu,Klodjan Stafa,Claudio Derada Troletti,Joon Y. Boon,Shamol Saha,Liliane Glauser,Adamantios Mamais,Allison Citro,Katherine L. Youmans,Li Qun Liu,Bernard L. Schneider,Patrick Aebischer,Zhenyu Yue,Rina Bandopadhyay,Marcie A. Glicksman,Darren J. Moore,James J. Collins,James J. Collins,Benjamin Wolozin +22 more
TL;DR: RGS2 is identified as a promising target for interfering with neurodegeneration due to LRRK2 mutations in PD patients and found that RGS2 regulates L RRK2 function and neuronal toxicity through its effects on kinase activity and independently of GTPase activity, which reveals a novel mode of action for GAP proteins.